GGrantIndex
Sort

46,585 grants matching heart failure

Mechanisms and Treatment of Cardiac and Skeletal Muscular Dysfunction in Barth Syndrome

$428,186
Christina A. Pacak · University Of Florida · R01 · FY2020 · HL

Gene Therapy for Long-Term Myocardial Protection

$428,146
Victor J Dzau · Duke University · R01 · FY2010 · HL

How do CNS fibroblasts regulate the response to neuroinflammation?

$428,134
Richard Daneman · University Of California, San Diego · R01 · FY2024 · NS

Regulation of Heart Function by a Gata4-Fog2 transcriptional complex

$428,125
William T Pu · Boston Children'S Hospital · R01 · FY2010 · HL

Regulation of MutL-gamma function in mediating crossing over in mammalian meiosis

$428,112
Paula Elaine Cohen · Cornell University · R01 · FY2020 · HD

Targeting Mitochondrial Cyclophilin D in Vascular Oxidative Stress and Hypertension

$427,996
Sergey Dikalov · Vanderbilt University Medical Center · R01 · FY2020 · HL

Single Cell Imaging of the Heart

$427,989
Ralph Weissleder · Massachusetts General Hospital · R01 · FY2015 · HL

The Role of PARP-SIR2 Signaling in Heart Failure

$427,954
Mahesh P Gupta · University Of Chicago · R01 · FY2007 · HL

Epicardial Contribution to the Developing and Postnatal Heart

$427,916
William T Pu · Boston Children'S Hospital · R01 · FY2010 · HL

Validation of Apnea Risk Evaluation System Sleep Scoring

$427,888
Daniel J Levendowski · Advanced Brain Monitoring, Inc. · R44 · FY2006 · HL

Clinical and Statistical Support Core/Loyd

$427,863
Ivan M Robbins · Vanderbilt University · P01 · FY2015 · HL

In vivo probes for the APJ receptor.

$427,829
Rangan Maitra · Research Triangle Institute · R01 · FY2014 · HD

Reprogramming Non-myocytes to Cardiomyocytes in vivo

$427,812
Richard T Lee · Harvard University · R01 · FY2017 · HL

Reprogramming Non-myocytes to Cardiomyocytes in vivo

$427,812
Richard T Lee · Harvard University · R01 · FY2019 · HL

Nanostructured Ultrafiltration Membranes for Biological Applications

$427,811
Oleg G. Polyakov · Synkera Technologies, Inc. · R44 · FY2010 · GM

Endothelial control of IFN-gamma and i-NOS in pathogenic T cells

$427,793
Jordan S Pober · Yale University · P01 · FY2007 · HL

REGULATION OF MITOCHONDRIAL ENERGETICS BY INTRACELLULAR IONS

$427,779
Brian O'Rourke · Johns Hopkins University · P01 · FY2009 · HL

The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial

$427,742
David Alan Drew · Tufts Medical Center · R01 · FY2021 · DK

The function of Runx1 in cardiac fibroblasts and post-myocardial infarction healing

$427,737
Xing Fu · Louisiana State Univ Agricultural Center · R01 · FY2022 · HL

Ryanodine receptor structure and function in heart failure

$427,700
Andrew R Marks · Columbia University Health Sciences · P01 · FY2025 · HL

Roles of Rad and other CaV1.2 neighboring proteins in regulating cardiac function in health and disease

$427,700
Steven O Marx · Columbia University Health Sciences · P01 · FY2025 · HL

Roles of Rad and other CaV1.2 neighboring proteins in regulating cardiac function in health and disease

$427,700
Steven O Marx · Columbia University Health Sciences · P01 · FY2023 · HL

Ryanodine receptor structure and function in heart failure

$427,700
Andrew R Marks · Columbia University Health Sciences · P01 · FY2023 · HL

ROS signaling and NOS uncoupling in pulmonary vascular disease

$427,669
Hunter Clay Champion · University Of Pittsburgh At Pittsburgh · P01 · FY2014 · HL

Molecular Control of Muscle Fuel Metabolism

$427,627
Daniel Patrick Kelly · University Of Pennsylvania · R01 · FY2019 · DK